scispace - formally typeset
Journal ArticleDOI

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Janet D. Rowley
- 01 Jun 1973 - 
- Vol. 243, Iss: 5405, pp 290-293
TLDR
An unsuspected abnormality in all cells from the nine patients with chronic myelogenous leukaemia has been detected with quinacrine fluorescence and various Giemsa staining techniques, suggesting that there may be a hitherto undetected translocation between the long arm of 22 and thelong arm of 9, producing the 9q+ chromosome.
Abstract
CELLS from nine consecutive patients with chronic myelogenous leukaemia (CML) have been analysed with quinacrine fluorescence and various Giemsa staining techniques. The Philadelphia (Ph1) chromosome in all nine patients represents a deletion of the long arm of chromosome 22 (22q−)1,2. An unsuspected abnormality in all cells from the nine patients has been detected with these new staining techniques. It consists of the addition of dully fluorescing material to the end of the long arm of one chromosome 9 (9q+). In Giemsa-stained preparations, this material appears as an additional faint terminal band in one chromosome 9. The amount of additional material is approximately equal to the amount missing from the Ph1 (22q−) chromosome, suggesting that there may be a hitherto undetected translocation between the long arm of 22 and the long arm of 9, producing the 9q+ chromosome.

read more

Citations
More filters
Journal ArticleDOI

The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatment

TL;DR: Early evaluation of the fold change in ABCB1 mRNA expression may identify patients likely to be resistant to first- and second-generation TKIs and who may be candidates for alternative therapy.
Journal ArticleDOI

Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?

TL;DR: This review examines how NGS technologies in particular have contributed to “omics” approaches in cancer research, allowing for large-scale integrative analyses that consider hundreds of tumour samples, and takes a look at emerging opportunities provided by NGS and state-of-the-art third-generation sequencing technologies, particularly in the context of translational research.
Journal ArticleDOI

Multiple karyotypic changes in retinoblastoma tumor cells: Presence of normal chromosome No. 13 in most tumors

TL;DR: In this article, the frequency of chromosome aberrations in retinoblastoma tumor cells was quantified by analyzing the karyotypes from the tumor cells of chromosome No. 13.
Journal ArticleDOI

Imatinib Resistance: Obstacles and Opportunities

TL;DR: The identification of the Philadelphia chromosome and the subsequent discovery that it represents a translocation between the long arms of chromosomes 9 and 22 producing an aberrant tyrosine kinase, known as BCR-ABL1, has catalyzed the understanding and treatment of this hematologic malignancy.
Journal ArticleDOI

c-myc locus amplification and the acquisition of trisomy 8 in the evolution of chronic myeloid leukaemia

TL;DR: The association of c-myc gene amplification with the progression of chronic myeloid leukaemia in fourteen individuals is explored and it is suggested that trisomy 8 and locus amplification could represent alternative mechanisms for increasing c- myc gene dosage.
References
More filters
Journal ArticleDOI

New Technique for Distinguishing between Human Chromosomes

TL;DR: It seems probable, therefore, that the darker staining with Giemsa of these regions, after denaturation and annealing, indicates the presence of highly repetitive DNA.
Journal ArticleDOI

Technique for Identifying Y Chromosomes in Human Interphase Nuclei

TL;DR: This work investigated the possibility of positively identifying male nuclei in interphase by virtue of this staining property of the Y chromosome using quinacrine dihydro-chloride.
Journal ArticleDOI

Clinical Implications of Cytogenetic Variants in Chronic Myelocytic Leukemia (CML)

TL;DR: The development of other chromosomal abnormalities in Ph1 positive patients presaged the terminal stage of the disease.
Journal ArticleDOI

Philadelphia-Chromosome-Positive and -Negative Chronic Myelocytic Leukemia

TL;DR: Chromosomal studies were performed on 61 adult patients with "typical chronic myelocytic leukemia" and the Philadelphia (Ph1) chromosome was found in 43 patients, with equal sex distribution a year after diagnosis.
Related Papers (5)